CTCELLS
PrivateLast Round
Series B
Extension
Apr 1, 2026
Total Funding Raised
$15.39M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CTCELLS is a life sciences company that develops cancer diagnostics and cell-based immunotherapy solutions, including liquid biopsy platforms and NK cell-based therapeutics.
Sector
Telecommunications & Networking
Verticals
Consumer Electronics, Internet Providers, Wireless Infrastructure, E-commerce
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CTCELLS Comparables
Compare CTCELLS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Menarini Group | 71% | |
CTCELLS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Apr 1, 2026 | ||||
| Series B | Mar 22, 2022 | ||||
| Grant | Jun 22, 2021 | ||||
| Series A | Apr 21, 2021 |
Key People
Founding team and executive leadership
CTCELLS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| InterVest | Series B |
| UTC Investment | Series A, Series B |
| KISED | Grant |
| KB Securities | Series A |
| Mirae Asset Capital | Series B |
| Enlight Ventures | Series A, Series B |
| LSK Investment | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Raised $6.63M in a Series B Extension round.
- Nov 13, 2025
Grew 43% QoQ from 7 to 10 employees.
CTCELLS Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CTCELLS's valuation, stock price, and market status.